Product Benefits

• Dual-Action Glucose Control: Combines two different mechanisms of action—Vildagliptin increases insulin secretion and decreases glucagon, while Metformin reduces glucose production in the liver and improves insulin sensitivity.

• Superior Glycemic Regulation: Effectively lowers both fasting and post-meal (postprandial) blood glucose levels more efficiently than monotherapy.

• Reduced Risk of Complications: By maintaining stable blood sugar levels, it helps prevent long-term diabetic complications such as nerve damage (neuropathy), kidney damage (nephropathy), and eye problems (retinopathy).

• Low Hypoglycemia Risk: Unlike some other diabetes medications (like sulfonylureas), the combination in Aptin M has a lower risk of causing dangerously low blood sugar levels when used as directed.

• Weight Neutrality: Generally does not cause significant weight gain, making it a favorable choice for patients managing their BMI alongside diabetes.

• Gastrointestinal Comfort: When taken with or after meals, the formulation helps minimize the common stomach-related side effects often associated with Metformin.

Would you like me to generate a comparison table between Aptin M 50/500 and Aptin M 50/850 for your product page?